Reply: neuropathy as a potential complication of levodopa use in Parkinson's disease: a pharmacological and pharmacovigilance point of view.
Toth
Cory
C
Suchowersky
Oksana
O
Zochodne
Douglas
D
D000978:Antiparkinson Agents / Q000009:adverse effects*; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D010300:Parkinson Disease / Q000188:drug therapy*; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced* / Q000517:prevention & control*
D000978:Antiparkinson Agents; D007980:Levodopa